KZIA
Kazia Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.83 / 10
Netural
Fund flow analysis scores 7.66/10, reflecting robust inflows across small, medium, and large orders, although overall and extra-large flows are negative. This positive money flow is juxtaposed with an overwhelmingly bullish analyst consensus (100% Strong Buy) yet zero historical win rate for the sole analyst (Sean Lee from HC Wainwright). The market expectation is pessimistic, and the current price decline contrasts with the weighted analyst rating, creating mixed signals for investors.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-28
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate0.0%
What is the market sentiment for KZIA?
- KZIA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.83/10 (Netural).
